This correction would give manufacturers, for whom working with a notified body would be a novel experience, more time to navigate the waters and would reduce possible supply chain disruptions. This change would also release some of the pressure on notified bodies in terms of workload prior to the date of application of 26 May 2020.

If you currently have a class I medical device that would be up classified under the MDR it could be useful to assess the impact this change may have on your transition project. But take note that the formal adoption by the European Parliament still needs to take place.

In the field of In Vitro Diagnostics (IVDs) this corrigendum triggers speculation. Would this be the precursor of an IVDR corrigendum potentially granting IVD-Directive self-certified devices that are up-classified under the IVDR (which is the large majority of IVDs) more time to transition? Time will tell….

Should you want to discuss this more in depth with one of our consultants, please do not hesitate to get in touch with us.



ISO Certified
ISO 13485 and ISO 27001


Website by Contents by Qarad Terms and conditions  Privacy policy  Cookie policy 


This website uses cookies to enhance your surfing experience.
Certain webfunctions rely on the usage of these cookies.
If you want more information regarding our cookie policy, you may visit this link.